Your browser doesn't support javascript.
loading
Co-occurring BRCA2/SPOP Mutations Predict Exceptional Poly (ADP-ribose) Polymerase Inhibitor Sensitivity in Metastatic Castration-Resistant Prostate Cancer.
Orme, Jacob J; Taza, Fadi; De Sarkar, Navonil; Tewari, Alok K; Arsalan Naqvi, Syed; Riaz, Irbaz B; Childs, Daniel S; Omar, Noha; Adra, Nabil; Ashkar, Ryan; Cheng, Heather H; Schweizer, Michael T; Sokolova, Alexandra O; Agarwal, Neeraj; Barata, Pedro; Sartor, Oliver; Bastos, Diogo; Smaletz, Oren; Berchuck, Jacob E; McClure, Heather; Taplin, Mary-Ellen; Aggarwal, Rahul; Sternberg, Cora N; Vlachostergios, Panagiotis J; Alva, Ajjai S; Mehra, Niven; Nelson, Peter S; Hwang, Justin; Dehm, Scott M; Shi, Qian; Fleischmann, Zoe; Sokol, Ethan S; Elliott, Andrew; Huang, Haojie; Bryce, Alan; Marshall, Catherine H; Antonarakis, Emmanuel S.
Afiliación
  • Orme JJ; Department of Medical Oncology, Mayo Clinic, Rochester, MN, USA; Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN, USA.
  • Taza F; Division of Hematology & Medical Oncology, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.
  • De Sarkar N; Department of Pathology and Cancer Center, Medical College of Wisconsin, Milwaukee, WI, USA.
  • Tewari AK; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
  • Arsalan Naqvi S; Division of Hematology and Oncology, Mayo Clinic, Scottsdale, AZ, USA.
  • Riaz IB; Division of Hematology and Oncology, Mayo Clinic, Scottsdale, AZ, USA.
  • Childs DS; Department of Medical Oncology, Mayo Clinic, Rochester, MN, USA.
  • Omar N; Ascension St Agnes Hospital, Baltimore, MD, USA.
  • Adra N; Division of Hematology & Medical Oncology, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.
  • Ashkar R; Division of Hematology & Medical Oncology, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.
  • Cheng HH; University of Washington and Fred Hutchinson Cancer Center, Seattle, WA, USA.
  • Schweizer MT; University of Washington and Fred Hutchinson Cancer Center, Seattle, WA, USA.
  • Sokolova AO; Oregon Health Sciences University, Portland, OR, USA.
  • Agarwal N; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
  • Barata P; UH Seidman Cancer Center, Cleveland, OH, USA.
  • Sartor O; Department of Medical Oncology, Mayo Clinic, Rochester, MN, USA.
  • Bastos D; Oncology Center, Hospital Sírio-Libanês, São Paulo, Brazil.
  • Smaletz O; Hospital Israelita Albert Einstein, São Paulo, Brazil.
  • Berchuck JE; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
  • McClure H; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
  • Taplin ME; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
  • Aggarwal R; University of California San Francisco, San Francisco, CA, USA.
  • Sternberg CN; Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY, USA.
  • Vlachostergios PJ; Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY, USA.
  • Alva AS; University of Michigan, Ann Arbor, MI, USA.
  • Mehra N; Radboud University, Nijmegen, The Netherlands.
  • Nelson PS; University of Washington and Fred Hutchinson Cancer Center, Seattle, WA, USA.
  • Hwang J; Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN, USA.
  • Dehm SM; Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN, USA; Masonic Cancer Center, Minneapolis, MN, USA; Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, USA; Department of Urology, University of Minnesota, Minneapoli
  • Shi Q; Department of Medical Oncology, Mayo Clinic, Rochester, MN, USA; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.
  • Fleischmann Z; Foundation Medicine Inc, Cambridge, MA, USA.
  • Sokol ES; Foundation Medicine Inc, Cambridge, MA, USA.
  • Elliott A; Caris Life Sciences, Irving, TX, USA.
  • Huang H; Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN, USA.
  • Bryce A; Division of Hematology and Oncology, Mayo Clinic, Scottsdale, AZ, USA.
  • Marshall CH; Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Antonarakis ES; Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN, USA; Masonic Cancer Center, Minneapolis, MN, USA. Electronic address: anton401@umn.edu.
Eur Urol Oncol ; 2023 Dec 09.
Article en En | MEDLINE | ID: mdl-38072760
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Eur Urol Oncol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Eur Urol Oncol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos